Currently, there are 6 potential SARS-CoV-2 vaccine platforms that are being manufactured and tested in animals and/or humans. They are:
mRNA
DNA
Subunit (components [i.e., antigens] of the virus)
Virus-like particles displaying subunits
Whole virus (inactivated) — meaning killed
Whole virus (attenuated) — meaning weakened
Below is a table listing advantages and disadvantages of some of these vaccine platforms that have been developed and are currently in testing for SARS-CoV and MERS-CoV from Prompetchara et al. 2020.